| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-5793(02)02918-6 |
| P698 | PubMed publication ID | 12095637 |
| P2093 | author name string | Shi Yu Yang | |
| Geoffrey Goldspink | |||
| P2860 | cites work | Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle | Q29615169 |
| Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle | Q31929653 | ||
| Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload | Q33674248 | ||
| Sequence of cDNA encoding human insulin-like growth factor I precursor | Q34055481 | ||
| C2C12 cells: biophysical, biochemical, and immunocytochemical properties | Q34329764 | ||
| Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. | Q34433058 | ||
| The potential of muscle stem cells | Q34434476 | ||
| Exon duplication and divergence in the human preproglucagon gene | Q34713786 | ||
| Two insulin-like growth factor I messenger RNAs are expressed in human liver | Q35583911 | ||
| Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1. | Q36532809 | ||
| A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone | Q37178897 | ||
| Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin | Q40786763 | ||
| Identification and purification of an intrinsic human muscle myogenic factor that enhances muscle repair and regeneration | Q40804383 | ||
| Insulin and insulin-like growth factor-I responsiveness and signalling mechanisms in C2C12 satellite cells: effect of differentiation and fusion | Q41128395 | ||
| Growth factors in skeletal muscle regeneration | Q41276495 | ||
| Effects of aging on skeletal muscle regeneration | Q43490339 | ||
| Skeletal muscle regeneration in very old rats | Q43586952 | ||
| Identification of pro-epidermal growth factor and high molecular weight epidermal growth factors in adult mouse urine | Q43589833 | ||
| Insulin-like growth factor I accelerates gastric ulcer healing by stimulating cell proliferation and by inhibiting gastric acid secretion | Q43719235 | ||
| ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression | Q43852566 | ||
| Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cells | Q46577736 | ||
| Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. | Q52129352 | ||
| Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. | Q52178500 | ||
| Changes in muscle fibre type, muscle mass and IGF-I gene expression in rabbit skeletal muscle subjected to stretch. | Q52194733 | ||
| Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. | Q52200362 | ||
| IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle | Q73010272 | ||
| Skeletal muscle satellite cell populations in healthy young and older men and women | Q73179574 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myoblast | Q1956694 |
| P304 | page(s) | 156-160 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation | |
| P478 | volume | 522 |
| Q79420599 | A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor |
| Q38253594 | A review on the mechanisms of blood-flow restriction resistance training-induced muscle hypertrophy |
| Q40013231 | A study of the induction of mechano growth factor expression in an in vitro system |
| Q87113170 | A synthetic mechano-growth factor E peptide promotes rat tenocyte migration by lessening cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signaling pathway |
| Q35852683 | Age-related loss of muscle mass and strength |
| Q45826802 | Ageing is associated with diminished muscle re-growth and myogenic precursor cell expansion early after immobility-induced atrophy in human skeletal muscle. |
| Q28575065 | Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy |
| Q34234465 | Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. |
| Q45146066 | Antisense oligonucleotides and short interfering RNAs silencing the cyclin-dependent kinase inhibitor p21 improve proliferation of Duchenne muscular dystrophy patients' primary skeletal myoblasts |
| Q21143763 | Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans |
| Q58749611 | Can Plasma Rich in Growth Factors Be Safe for Parental Use? A Safety Study in the Canine Model |
| Q37056291 | Cellular and molecular events controlling skeletal muscle mass in response to altered use. |
| Q44719055 | Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products. |
| Q38110504 | Characterization and regulation of mechanical loading-induced compensatory muscle hypertrophy |
| Q59134960 | Chronic infection stunts macrophage heterogeneity and disrupts immune-mediated myogenesis |
| Q63805310 | Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans |
| Q41891522 | Design and fabrication of a biodegradable, covalently crosslinked shape-memory alginate scaffold for cell and growth factor delivery |
| Q48106817 | Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. |
| Q39664593 | Differential induction of cellular proliferation, hypertrophy and apoptosis in H9c2 cardiomyocytes by exogenous tissue factor |
| Q36459287 | E-peptides control bioavailability of IGF-1. |
| Q87450734 | Effect of MGF E-peptide on anabolic and proteolytic signaling pathways in rat m. gastrocnemius medialis |
| Q31129740 | Effects of strain on contractile force and number of sarcomeres in series of Xenopus laevis single muscle fibres during long-term culture. |
| Q28295716 | Emerging drugs for sarcopenia: age-related muscle wasting |
| Q63478106 | Enhanced satellite cell proliferation with resistance training in elderly men and women |
| Q38945114 | Examination of alternate codon bias solutions for expression and purification of recombinant mechano-growth factor in Escherichia coli |
| Q36068056 | Exercise and circulating insulin-like growth factor I. |
| Q57476677 | Exercise and the control of muscle mass in human |
| Q44401232 | Expression and Splicing of the Insulin‐Like Growth Factor Gene in Rodent Muscle is Associated with Muscle Satellite (stem) Cell Activation following Local Tissue Damage |
| Q39463770 | Expression and purification of two alternative peptides for mechano-growth factor in Escherichia coli |
| Q42462943 | Expression and subcellular localization of mechano-growth factor in osteoblasts under mechanical stretch |
| Q53942483 | Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. |
| Q57024418 | Expression of insulin-like growth factor I, insulin-like growth factor binding proteins, and collagen mRNA in mechanically loaded plantaris tendon |
| Q39437832 | Expression of muscle anabolic and metabolic factors in mechanically loaded MLO-Y4 osteocytes |
| Q54490830 | Expression of specific IGFBPs is associated with those of the proliferating and differentiating markers in regenerating rat plantaris muscle. |
| Q34135241 | Extrinsic regulation of satellite cell specification |
| Q36234586 | Fiber-type composition of the human jaw muscles--(part 1) origin and functional significance of fiber-type diversity |
| Q36956383 | Functional deficits and insulin-like growth factor-I gene expression following tourniquet-induced injury of skeletal muscle in young and old rats |
| Q34275723 | Gene expression in muscle in response to exercise |
| Q34576814 | Gene therapy progress and prospects: Duchenne muscular dystrophy |
| Q44048126 | Generation and evaluation of antibodies against human MGF E-peptide by reverse phase protein microarray and reverse competitive ELISA. |
| Q26746405 | Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing |
| Q33569163 | Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? |
| Q36333933 | Human Eb peptide: not just a by-product of pre-pro-IGF1b processing? |
| Q47366049 | Human IGF-I propeptide A promotes articular chondrocyte biosynthesis and employs glycosylation-dependent heparin binding |
| Q38554891 | Human sports drug testing by mass spectrometry |
| Q54282437 | IGF-1 colocalizes with muscle satellite cells following acute exercise in humans. |
| Q36320501 | IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors. |
| Q27024703 | IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism? |
| Q51779098 | Impact of treadmill locomotor training on skeletal muscle IGF1 and myogenic regulatory factors in spinal cord injured rats. |
| Q42701900 | Impairment of IGF-I expression and anabolic signaling following ischemia/reperfusion in skeletal muscle of old mice |
| Q90482471 | Insulin-Like Growth Factor I Regulation and Its Actions in Skeletal Muscle |
| Q35022643 | Insulin-like growth factor I (IGF-1) Ec/Mechano Growth factor--a splice variant of IGF-1 within the growth plate. |
| Q35587426 | Insulin-like growth factor action and skeletal muscle growth, an in vivo perspective |
| Q34429527 | Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor |
| Q63342601 | Insulin-like growth factors effects on the expression of myogenic regulatory factors in gilthead sea bream muscle cells |
| Q40335819 | Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles. |
| Q53165439 | Is the -174 C/G polymorphism of the IL6 gene associated with elite power performance? A replication study with two different Caucasian cohorts. |
| Q91687596 | Local Vibration Stimuli Induce Mechanical Stress-Induced Factors and Facilitate Recovery From Immobilization-Induced Oxidative Myofiber Atrophy in Rats |
| Q43568840 | Mechano growth factor (MGF) promotes proliferation and inhibits differentiation of porcine satellite cells (PSCs) by down-regulation of key myogenic transcriptional factors |
| Q33883445 | Mechano growth factor, a splice variant of IGF-1, promotes neurogenesis in the aging mouse brain |
| Q50210424 | Mechano-growth factor enhances differentiation of bone marrow-derived mesenchymal stem cells. |
| Q46007172 | Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells. |
| Q38133542 | Mechano-regulation of alternative splicing |
| Q47701394 | Mechanobiology of young and aging tendons: In vivo studies with treadmill running |
| Q41683501 | Migration and proliferation of human mesenchymal stem cells is stimulated by different regions of the mechano-growth factor prohormone |
| Q38761926 | Mimicking exercise in three-dimensional bioengineered skeletal muscle to investigate cellular and molecular mechanisms of physiological adaptation |
| Q33735493 | Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration |
| Q39571282 | Modelling in vivo skeletal muscle ageing in vitro using three-dimensional bioengineered constructs. |
| Q37257924 | Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults |
| Q36756794 | Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization |
| Q80186853 | Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats |
| Q30434197 | Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice |
| Q44533330 | Muscle satellite (stem) cell activation during local tissue injury and repair |
| Q33752882 | Myoferlin is required for insulin-like growth factor response and muscle growth |
| Q93050407 | Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers |
| Q38094701 | New Modulators for IGF-I Activity within IGF-I Processing Products |
| Q36538153 | New fundamental resistance exercise determinants of molecular and cellular muscle adaptations |
| Q47754257 | Overload training inhibits phagocytosis and ROS generation of peritoneal macrophages: role of IGF-1 and MGF. |
| Q34047251 | PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds. |
| Q43195170 | Passive mechanical forces upregulate the fast myosin heavy chain IId/x via integrin and p38 MAP kinase activation in a primary muscle cell culture |
| Q83150778 | Peripheral venous occlusion causing cardiac hypertrophy and changes in biological parameters in rats |
| Q26778654 | Physiological and Neural Adaptations to Eccentric Exercise: Mechanisms and Considerations for Training |
| Q36881964 | Plasticity of human skeletal muscle: gene expression to in vivo function. |
| Q35962591 | Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations |
| Q38075849 | Potential mechanisms for a role of metabolic stress in hypertrophic adaptations to resistance training |
| Q58615342 | Regulation of Muscle Growth in Early Postnatal Life in a Swine Model |
| Q42102725 | Research on mechano growth factor: its potential for optimising physical training as well as misuse in doping |
| Q36066585 | Role of IGF-I in follistatin-induced skeletal muscle hypertrophy |
| Q30446473 | Running on empty: how p53 controls INS/IGF signaling and affects life span |
| Q90325612 | Satellite cell function, intramuscular inflammation and exercise in chronic kidney disease |
| Q33816665 | Satellite cells and the muscle stem cell niche |
| Q26777962 | Satellite cells in human skeletal muscle plasticity |
| Q35003261 | Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle |
| Q35145583 | Skeletal muscle as an artificial endocrine tissue |
| Q38095767 | Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways |
| Q36325014 | Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. |
| Q34322871 | Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications |
| Q41682420 | Specific titin and myomesin domains stimulate myoblast proliferation. |
| Q35547307 | Stem cell activation in skeletal muscle regeneration. |
| Q34097153 | Stimulation of mechano-growth factor expression by myofibrillar proteins in murine myoblasts and myotubes. |
| Q54572065 | Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans. |
| Q35567203 | Sustained delivery of MGF peptide from microrods attracts stem cells and reduces apoptosis of myocytes |
| Q45732506 | Synthesis, characterization, and biocompatibility of a novel biomimetic material based on MGF-Ct24E modified poly(D, L-lactic acid). |
| Q37039373 | The E-domain region of mechano-growth factor inhibits cellular apoptosis and preserves cardiac function during myocardial infarction |
| Q24307354 | The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle |
| Q37789610 | The Mechanisms of Muscle Hypertrophy and Their Application to Resistance Training |
| Q34548920 | The Role of GH and IGF-I in Mediating Anabolic Effects of Testosterone on Androgen-Responsive Muscle |
| Q36224171 | The behaviour of satellite cells in response to exercise: what have we learned from human studies? |
| Q33619027 | The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity |
| Q36915911 | The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology |
| Q44622913 | The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. |
| Q39432413 | The emerging role of alternative splicing in senescence and aging. |
| Q33841223 | The insulin-like growth factor (IGF)-I E-peptides are required for isoform-specific gene expression and muscle hypertrophy after local IGF-I production |
| Q37327278 | The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein |
| Q34213640 | The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism? |
| Q48104841 | The novel finding of four distinct prepro-IGF-I E domains in a perciform fish, Sciaenops ocellatus, during ontogeny |
| Q34323600 | The nuclear localization of MGF receptor in osteoblasts under mechanical stimulation |
| Q35937545 | The splicing of the IGF-I gene to yield different muscle growth factors |
| Q38805077 | The structure-function relationships of insulin-like growth factor 1 Ec in C2C12 cells |
| Q38046671 | The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development |
| Q53230711 | Therapeutic ultrasound affects IGF-1 splice variant expression in human skeletal muscle. |
| Q44963948 | Transcriptional regulation of IGF-I expression in skeletal muscle |
| Q37573464 | Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia |
| Q37707643 | Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength |
| Q62655508 | Zelluläre Regulation des Anabolismus und Katabolismus der Skelettmuskulatur bei Immobilität, im Alter und bei kritisch Kranken |
Search more.